What Should Specialty Pharmacists Know About the REVERCE Clinical Trial?

Kohei Shitara, MD, Department of Gastrointestinal Oncology of National Cancer Center Hospital East, Japan, discusses the importance of the REVERCE clinical trial for specialty pharmacists.

Related Content:

ConferenceSpecialty PharmacyOncology

Stroke Survivors Are Less Likely to Quit Smoking Than Cancer Survivors

FDA Grants Rare Pediatric Disease Designation for Treatment of HLHS in Infants

Cancer Caregivers Face Mental Health Struggles During COVID-19 Pandemic